P throid progenitors in the bone marrow is regulated by the glycoprotein hormone erythropoietin (Epo). Low level constitutive Epo production is required for normal maintenance of erythropoiesis. Decreased tissue oxygen tension induces Epo production in the kidney and liver resulting in enhanced output of erythrocytes from the bone marrow and increased oxygen transport capacity of the bl00d.l'~ Following hypoxic stress, Epo mRNA levels in the kidneys i n~r e a s e~-~ as a result of enhanced Epo gene transcription. ' To investigate the control of Epo gene expression, Goldberg et a18 screened a number of primary and established kidney and liver cell lines for the constitutive and induced expression of Epo. They found that the human hepatoma cell lines, Hep3B and HepG2, respond to hypoxia with enhanced Epo mRNA levels and secretion of Epo protein. ' A more thorough understanding of the transduction pathway from low oxygen tension to enhanced Epo gene expression requires a means of accurately quantitating Epo mRNA. Conventional methods of mRNA analysis, such as Northern blot and dot blot hybridization, permit only crude quantitation of mRNA. The sensitivity of these methods is too low to detect Epo-mRNA in uninduced cells or in a small number of cells. In contrast, ribonuclease protection has provided specific and accurate quantitation of low levels of Epo mRNA.9-"
Because of its high sensitivity, the polymerase chain reaction (PCR) has been widely used to amplify cDNA copies of low abundance mRNA.I2*l3 However, the yield of PCR products fails to provide accurate measurement of the amount of mRNA present in the starting material. The main constraint in obtaining quantitative data is inherent in the amplification process. Because of the exponential increase of products with each cycle of amplification, even very small differences in reaction conditions can affect the efficiency of amplification, which in turn can markedly alter product yield independently of the amount of template input. This problem can be circumvented by the addition of a competitive template that is coamplified with the same efficiency as that of the cDNA template of interest.14 We have adapted competitive PCR for the quantitation of Epo mRNA from rat tissue and Hep3B cells. These accurate measurements provide new insights on critical aspects of Epo gene regulation, including is, to a large extent, transcriptional. When Hep3B cells were incubated in the presence of decreasing O2 tension from 160 to 7 mm Hg, there was a monotonic increase in Epo mRNA to 50 to 100 times the normoxic level. Hyperoxia did not suppress basal expression. When cells were incubated at a Po, of 7 mm Hg, induction of Epo mRNA was first noted at 30 minutes and was maximal at 5 to 6 hours.
After Epo mRNA was boosted by a 4-hour hypoxic incubation, cells were then exposed to normoxia, which shut off further transcription of the Epo gene. The decay of Epo mRNA levels closely followed first order kinetics with a halflife of 2 hours, an effective measurement of message stability.
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the tissue distribution of mRNA expression, the response to a wide range of oxygen tensions, and the kinetics of induction and decay of Epo mRNA.
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (SD-strain) weighing 200 to 250 g were purchased from the Charles River Laboratories (Wilmington, MA). Different degrees of anemia were induced by single or repeated intraperitoneal injections of phenylhydrazine (60 mg/kg body weight). Seven hours to 4 days after the last injection, the rats were bled to death from the dorsal aorta under ether anesthesia. Kidneys, liver, spleen, heart, and lungs were removed and snap-frozen in liquid N2. Hematocrit (Hct) levels were determined in quadruplicate by spinning microcapillaries in a hematocrit centrifuge. Epo protein in the plasma was measured by a sensitive radioimmunoassay as described. 15 The frozen organs were weighed and homogenized in 4 mol/L guanidinium isothiocyanate with 0.1 mol/L 8-mercaptoethanol and 10% N-lauryl-sarcosine using a Polytron homogenizer (Kinematica GmbH, Luzem, Switzerland) at setting IO for 15 seconds. Total RNA was isolated by centrifugation through 5.7 mol/L CsC1I6 and precipitation in ethanol. After redissolving the sample in diethyl pyrocarbonate-treated water, the concentration was determined by absorbance at 260 nm. To check the integrity of the RNA, aliquots were run in a 1.1 % formaldehyde/agarose gel.
Cell Culture
Hep3B cells were obtained from American Type Culture Collection and cultured in alpha MEM-medium (JRH Biosciences, Lenexa, KS) 618 FANDREV AND BUNN supplemented with 10% defined, supplemented calf serum (Hyclone, Logan, UT), penicillin (100 U/mL), and streptomycin (100 pg/mL). Hep3B cells were grown to confluency in 25-cm2 tissue culture flasks (Ciba Coming, Corning, NY) and maintained in a well-humidified 95% air, 5% C 0 2 incubator at 37°C.
The flasks were fitted with rubber stoppers providing gas inlet and outlet through 18-g needles. Experimental gases containing 1% (7.5 mm Hg) to 30% (225 mm Hg) O,, 5% COz, and the balance gas N2 were mixed in an Environics computerized gas standards generator (Environics Series 200, West Wilmington, CT) according to the desired O2 concentration. Gas mixtures were hydrated and circulated at a constant flow of 300 cc/min through the tissue culture flasks. The flasks were mounted on a rocking platform in the incubator and shaken with a frequency of 25 times per minute to ensure equilibration of the medium with the Poz in the flasks. The PO, was monitored by analyzing the outflow gas in an automated blood gas analyzer (Instrumentation Laboratory, Lexington, MA).
At the end of the experiments, the cells were washed twice with sterile phosphate-buffered saline and lysed with 4 mol/L guanidiniumisothiocyanate with 0. I mol/L P-mercaptoethanol. Total RNA was isolated as described above for rat tissue.
Reverse Transcription of RNA Into cDNA
Five micrograms of total RNA from rat tissue or 350 ng to 1 fig of total RNA from Hep3B cells were reverse transcribed into first strand cDNA. Primers for the avian myoblastosis virus reverse transcriptase (AMV-Super RT, 4 U/reaction; Molecular Biology Resources, Milwaukee, WI) were either oligo dT(15, or random hexamers (Boehringer Mannheim Inc, Indianapolis, IN) used at a concentration of 4 pmol/L. After initial denaturation of the RNA at 68°C to eliminate possible secondary structure, the reaction was allowed to proceed for 1 hour at 42°C. The transcription reaction was terminated by boiling the samples for IO minutes. The cDNA-stocks were kept at -20°C until quantitation by competitive PCR.
In all experiments the presence of possible contaminating genomic DNA from the cells, cDNA from previous PCRs, or plasmid DNA was checked by control reactions. Amplification was performed on samples in which: (1) reverse transcriptase was omitted from the reverse transcription reaction mixture; or (2) no RNA was added to the reaction mixture.
Competitive PCR
PCR was performed in 1 X PCR-buffer (50 mmol/L Tris-HCI, pH 8.3, 50 mmol/L KCl; 1.5 mmol/L MgCI2; 0.001% wt/vol gelatin), 200 pmol/L of each dNTP, 0.3 pmol/L of each 5' and 3' primer and 5 U/mL of Taq polymerase (Perkin-Elmer, Cetus, Nonvalk, CT) in a final volume of 100 pL. To each tube, 1 pL of cDNA of unknown concentration and 1 pL of a dilution series containing known amounts of the mutant competitor were added. PCR was then performed for 35 to 50 cycles after an initial denaturation for 3 minutes at 94°C. Results with competitive PCR are not cycle dependent. Cycle number was chosen to give bands readily visualized after ethidium staining. The amplification profile of each cycle consisted of denaturation at 95°C for 1 minute, primer annealing at 58°C for 1 minute 30 seconds, and elongation at 72°C for 3 minutes.
A mutant competitor DNA (mutDNA, Fig lA, top) was prepared from full-length Epo genomic DNA by a PCR-based method." These mutations enable amplified PCR product from wild-type cDNA to be readily distinguished from the mutant DNA competitor: the former can be cut with Acc I and the latter with HindIII but not vice versa. The cut DNA-fragments were subsequently separated on a 2% agarose gel, stained with ethidium bromide (0.5 pg/pL), and visualized under UV light.
A schematic drawing of the bands on such a gel is shown in Fig  IA, bottom. The uncut PCR product appears as a band of 253 base pairs (bp) reflecting the amplified DNA fragment spanned by the pair of primers. After digestion with restriction enzymes, a typical banding pattern emerges depending on the relative amounts ofthe two different DNAs amplified in the PCR. If wild-type cDNA in the PCR reaction is in marked excess, it will be preferentially amplified. Accordingly, most of the product will be cut with Acc I. On the ethidium bromidestained gel, a 201-bp fragment appears in the lane loaded with Acc I-cut DNA, whereas little of the full-length 253-bp fragment is cut by HindIII. However, with a large excess of competitor mutDNA, the opposite pattern is observed: the 253-bp full-length fragment in the Acc I lane and the cut 215-bp fragment in the Hind111 lane. If the amount of input cDNA and mutDNA are the same, the PCR products will be equally cut with Acc I and HindIII. We used a twofold dilution series for each titration. Visual inspection of the ethidiumstained gel permitted interpolation between two near equivalence points with an accuracy of ?20% (mean f 1 SD). Densitometric scanning of the gels provided no enhancement of accuracy or reproducibility. Replicate measurements of 8 samples gave essentially identical results. Because the quantitation of Epo mRNA in this study extended over two orders of magnitude, 20% (mean f 1 SD) accuracy enabled us to obtain highly significant and reproducible results.
In Vitro Transcription of Epo-cDNA
The eukaryotic expression vector pSG5 (Stratagene, La Jolla, CA), containing the full-length Epo cDNA, served as a template for in vitro transcription (Stratagene). According to the manufacturer's instructions, T7 polymerase was used to transcribe Epo-RNA. The RNA was phenol/chloroform extracted, ethanol precipitated, and quantified by absorbance at 260 nm. In vitro transcribed RNA was used for RT from 7.8 pg to 7.8 ng, added to 1 pg of total RNA from normoxic Hep3B cells that had been shown to contain less than 0.1 attamoles (amol) of Epo mRNA/pg RNA.
RESULTS
Eficiency of Reverse Transcription
Full-length wild-type Epo m R N A was isolated following transcription in a cell-free incubation. A dilution series of this Epo riboprobe (added t o 1 pg of R N A from normoxic Hep3B cells) was quantitated by competitive PCR. Over the concentration range from 7.8 pg to 7.8 ng per RT-reaction, 35 f 3% of the R N A was transcribed into cDNA. It is likely that native Epo m R N A is reverse transcribed with similar efficiency. Therefore, the equivalence points shown in the results below were corrected for a 35% recovery of Epo cDNA.
Rut Experiments
Competitive PCR was used for quantitation of Epo m R N A extracted from different organs (Table I ). Systematically lowering the Hct level led to a n exponential increase of the Epo m R N A levels in the rat kidneys (Fig 2B) as well as a corresponding increase of Epo protein levels in the plasma (Fig 2A) . In severely anemic rats, kidney Epo m R N A was 300-fold greater than values obtained i n normal animals. Kidney m R N A correlated inversely with Hct levels (r = -0.71) and directly with plasma Epo levels ( r = 0.77) (Fig 3) .
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For personal use only. on October 25, 2017. by guest www.bloodjournal.org From No Epo mRNA could be pg RNA, respectively. These signals were at the limit of dedetected in heart tissue from normal or anemic rats or in lung tissue from normal rats. A small but reproducible signal was observed in lungs of severely anemic animals (Hct 0. I8 and 0.20). Comparably low but reproducible signals were also obtained from the spleens of rats regardless of whether they were anemic. In the anemic lung and spleen, competitive PCR titrations gave corrected values of assays, the equivalence points were around 0.0007 amol/pg RNA and 0.00 I I amol/ tectability of our assay and represent approximately 400 and 800 molecules of Epo mRNA/pg RNA, respectively. Similarly low levels were observed in the livers of nonanemic rats. Epo mRNA was increased about IO-fold in livers of severely anemic rats (0.007 v 0.0007 amollpg RNA). Taking into account the higher organ weight, the contribution of the liver to the total amount of Epo mRNA in anemia ranged from 16% to 24% (n = 
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Hep3B Cells
Hep3B cells produce Epo when exposed to hypoxia. This increased protein secretion into the medium is preceded by a 50-to 100-fold increase in mRNA levels when the cells are exposed to 1% (7.5 mm Hg) O2 for 4 hours. Figure 4 depicts a representative 2% agarose gel with digested PCR products. For cells constantly shaken and flushed with 2 1% 0, (1 58 mm Hg), the competitive PCR titration gives a value of 0.07 amol Epo mRNA/pg total RNA, whereas the value for cells exposed to I% O2 is 7 amol/pg RNA. It can be calculated that at 21% 0, the average cell contains 0.6 copies of Epo mRNA per cell, whereas at 1% 02, each cell contains about 60 copies.* When Hep3B cells are incubated in air (21% 0,) without shaking in tissue culture flasks with gas impermeable bottoms, they become hypoxic because of diffusion-limited oxygen supply." These cells have a threefold higher Epo gene expression than under conditions wherein the flasks are constantly shaken and flushed with 21% O,-containing air (0.17 ? 0.02 v 0.06 ? 0.01 amol/pg RNA; n = 4 separate experiments). Thus, in subsequent experiments, Epo gene expression was maximally suppressed by incubating Hep3B cells at 2 1% O2 for 6 hours as described above. At the beginning of the experiment, the cells were switched to 1% (7.5 mm Hg) 0 2 and exposed for different time periods (Fig 5A) . As early as 30 minutes after the onset of hypoxia, a threefold increase in Epo mRNA levels could be observed. These levels peaked at 5 to 6 hours, reaching up to a 100-fold increase over basal (normoxic) mRNA levels. Longer exposure to hypoxia resulted in a decrease in Epo mRNA to a plateau of 40% to 50% of the maximal value. The time course for Epo mRNA induction following exposure to 100 pmol/L CoCl, is shown in Fig 5B. Although the values at 1,3, and 6 hours of exposure were similar to that observed with hypoxia (Fig 5A) , cobalt treatment resulted in a sustained level of Epo expression over the subsequent 18 hours.
After exposure of Hep3B cells to 1% O2 (7.5 mm Hg) for 4 hours, the gas was abruptly switched to 21% O2 (158 mm Hg) and the Epo mRNA levels deterKinetics ofEpo mRNA induction.
Epo mRNA half-life.
* At 21% 02-0.07 amol/pg total RNA, at 1% 0,-7.0 amol/pg. 1 amol = 6.0 X loz3 (Avogadro's number) X lo-'' = 6 X lo5 molecules. Therefore, 0.07 X 1.45 X lo5 X 6 X lo5 = 0.6 molecules. At 1% O2 there would be 100 times as many molecules. mined at the time points indicated in Fig 6. The message levels decreased in an exponential fashion (Fig 6, inset) with a half-life of the Epo mRNA of 2.0 hours.
Hep3B cells were exposed to oxygen tensions ranging from 228 to 7.5 mm Hg for 4 hours (Fig 7) . We found that hyperoxia (PO2 Effect of varying PO, on Epo mRNA levels. Expression (?f Epo in R NA in I he Rat
As shown in Fig 2, the induction of severe anemia in rats resulted in a 300-fold increase in Epo mRNA. Recently, Tan et all' showed that rats subjected to hypoxic hypoxia (7% 02) develop a 150-fold elevation of Epo mRNA. They and we detected reproducible signals from normoxic control kidneys that they quantified by a ribonuclease protection assay. The sensitivity of this assay is comparable to what we obtain with competitive PCR. However. Epo mRNA measurement by ribonuclease protection requires 50-to 100-fold more RNA than that needed for competitive PCR. In anemic mice, Koury et a19 reported a 500-fold increase of kidney Epo mRNA. However, in nonanemic controls levels were at the limit of detection of their ribonuclease protection assay.
The contribution of the liver to production of Epo under basal and hypoxic conditions is an issue of considerable pathophysiologic interest. Despite the use of highly sensitive assays detailed in this and other reports?" uncertainty re- mains as to whether the liver contributes significantly to total Epo production under normoxic circumstances. In hypoxic rats, Tan et all' found the contribution of liver Epo mRNA to be 25% to 50% of the total. As shown in Table 1 , we found that the liver contributed about 16% to 24% of the induced Epo mRNA in anemic rats, depending on the degree of anemia. For normal rats the amount of Epo mRNA in liver was difficult to quantitate because of the presence of additional amplification products. In contrast to these results in rats, mice have a smaller amount of Epo mRNA in liver, which has been shown to be age d e~e n d e n t .~.~ In view of these contrasting results, further study is needed to determine to what extent the hepatic contribution to Epo production varies among species and as a function of the type of hypoxic stress.
Ribonuclease protection assay' and competitive PCR (detailed in this report) were sensitive enough to allow detection of mRNA in the spleen and, to a lesser extent, in the lung. Epo mRNA levels were not significantly stimulated by anemia. Therefore, the physiologic significance of Epo gene expression in these two organs remains to be determined. Local paracrine production of Epo in macrophages" or autocrine production in hematopoietic progenitors2' may contribute to steady-state erythropoiesis.
Expression of Epo mRNA in Hep3B Cells
As shown in this report, Epo mRNA expression in Hep3B cells has several features in common with physiologic regulation of Epo in the kidney and liver. These include low level constitutive expression, the time course of induction by hypoxia and subsequent downregulation, the stability of Epo mRNA, and the response to graded hypoxia.
Definitive studies of hypoxiainduced Epo gene expression in cell lines require precise control of the oxygen tension to which the Epo-producing cells are exposed. Because of diffusion-limited O2 supply, the PO2 of cells cultured without shaking in gas impermeable flasks can be much lower than that of the incubation gas.18 When incubated in air under these conditions, we observed that Hep3B cells were modestly hypoxic and had three times
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higher Epo mRNA levels than cells incubated with gentle shaking. It is noteworthy that this low level constitutive expression at a Po2 of 158 mm Hg could not be further suppressed by hyperoxia. Thus the oxygen sensor, which is likely to be a heme protein;' seems to be fully saturated when cells are incubated in 2 I % 02.
Kinetics of induction. Our competitive PCR assay has enabled us to obtain new information on the time course of Epo mRNA induction following exposure of Hep3B cells to hypoxia (7 mm Hg). As early as 30 minutes a threefold increase in Epo mRNA levels was noted (Fig SA) . This lag period is consistent with a prior experiment showing that protein synthesis is necessary for induction of Epo mRNA expression and may be useful in planning experiments investigating the trans-acting factors that impact on 02-dependent gene expression.21 During further exposure to hypoxia, Epo mRNA levels reached their maximum at 5 to 6 hours. This time point for the peak Epo mRNA levels is in good agreement with the kinetics of Epo mRNA induction in animals. Bondurant and Koury4 found maximal levels in mice between 4 and 8 hours, whereas Jelkmann2' observed maximal Epo protein levels in rat kidneys about 6 hours after the onset of continuous hypoxic hypoxia.
After 6 to 8 hours of exposure to hypoxia (but not cobalt), Epo mRNA levels in Hep3B cells declined to about half maximum (Fig SA) . Downregulation of similar degree and time course has been noted with in vivo h y p o~i a .~~, '~ The mechanism for this phenomenon is unknown. Direct feedback inhibition by Epo protein has been ruled To our knowledge this is the first time that this decline has been shown at the level of Epo mRNA in vitro. Thus, Hep3B cells may provide a suitable model for further in vitro studies of this phenomenon. However, it is possible that the similar pattern of downregulation in vivo and in Hep3B cells is fortuitous. Although Hep3B cells grow well under hypoxia, the decrease in Epo mRNA levels could merely be a toxic effect of prolonged hypoxia.
mRNA stability. The results in Fig 6 present an accurate measurement of the rate of decay of Epo mRNA when hypoxic Hep3B cells were abruptly switched to normoxia. The half-time of 2.0 hours is in good agreement with a value of 1.5 hours previously obtained from Northern blots." However, competitive PCR avoids the highly inaccurate densitometry quantitation of autoradiograms. The accuracy of our data presented here is reflected by the clean first order decay of the Epo mRNA. The half-life of 2.0 hours can be regarded as a maximal value but very close to the true value because only a very low level of transcription occurs when these cells are equilibrated at 2 1% O2.I5 Actinomycin D cannot be used in these experiments because, when transcription is inhibited, the stability of Epo mRNA is artificially prolonged." The 2-hour half-life of Epo mRNA in vitro is comparable to the in vivo half-life of 1 hour noted when mice were abruptly switched from a hypoxic to a normoxic atmosphere. 6 Earlier studies have provided quantitation of Epo protein but not Epo mRNA in response to graded changes in oxygen tension.* Because Epo gene expression seems to be mainly regulated on the mRNA level, the accurate quantitation of Epo mRNA over a broad
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For personal use only. on October 25, 2017 . by guest www.bloodjournal.org From range of oxygen tensions should help to characterize better the oxygen sensor. T h e continuous increase in Epo m R N A with decreasing PO, (Fig 7) can be interpreted in light of recent in situ hybridization studies. Koury et alZ5 have provided convincing evidence that, in the mouse kidney, Epoproducing cells respond to increasing degrees of anemia with thresholdlike, all-or-none behavior. T h e a m o u n t of Epo m R N A per cell remained constant as the Hct level was decreased, but new cells expressing Epo m R N A were recruited. In Hep3B cells we observed a gradual increase in m R N A expression with increasing degrees of hypoxia (Fig 7) , rather than the thresholdlike behavior mentioned above. These results o n a hepatic cell line are fully consistent with recent in situ hybridization studies by Koury et alZ6 on livers of mice transgenic for the human Epo gene. Lowering the Hct level in these mice by repeated bleeding caused a n increase in the number of m R N A copies per cell rather than recruitment of additional hepatocytes expressing the Epo gene. Thus, the pattern of induction of Epo gene expression seems to differ in kidney a n d liver. Further definitive support for this con- 
